The earlier phase 3 study tested two doses against placebo, and the results ran the opposite way to intuition: 0.05 mg/kg/day met the primary endpoint (16/35 responders, p=0.007) while the higher 0.10 mg/kg/day dose failed it (8/32, p=0.16) [3]
Crucial for breaking down food and repairing body tissues
It is critical to understand what BPC-157 is NOT: It is not an FDA-approved drug
For now, 5-amino-1MQ appears to be a promising candidate for treating obesity and diabetes, as well as improving muscle function
Its cytoprotective effects were first characterized in the GI tract, but subsequent research has extended these findings to tendons, ligaments, bone, muscle, and even neural tissue
He noticed nothing he could confidently attribute to BPC-157 rather than the continued PT work